Literature DB >> 11282988

Bruton's tyrosine kinase is required for signaling the CD79b-mediated pro-B to pre-B cell transition.

T Kouro1, K Nagata, S Takaki, S Nisitani, M Hirano, M I Wahl, O N Witte, H Karasuyama, K Takatsu.   

Abstract

Formation of the pre-BCR complex is a critical check point during B cell development and induces the transition of pro-B to pre-B cells. CD79b (Igbeta) is a signaling component in the pre-BCR complex, since differentiation to the pre-B phenotype is induced by cross-linking the CD79b expressed on developmentally arrested pro-B cells from recombination-activating gene (RAG)-2-deficient mice. Bruton's tyrosine kinase (BTK) plays important roles in B cell development. However, its molecular mechanisms in early B cell development are not fully understood. To examine whether BTK functions in CD79b-mediated signaling for the pro-B/pre-B transition, we utilized RAG2/BTK double-knockout (DKO) mice. Pro-B cells from RAG2/BTK-DKO mice did not differentiate into pre-B cells following CD79b cross-linking, although tyrosine phosphorylation of cellular proteins including Erk1/2 and phospholipase C-gamma2 was induced in the same manner as RAG2-KO mice. BTK is phosphorylated after cross-linking of CD79b on RAG2-deficient pro-B cells. These findings suggest that BTK-dependent pathways downstream of CD79b are critical for the pro-B/pre-B transition and BTK-independent signaling pathways are also activated via the pre-BCR complex.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11282988     DOI: 10.1093/intimm/13.4.485

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  7 in total

1.  Disruption of Fnip1 reveals a metabolic checkpoint controlling B lymphocyte development.

Authors:  Heon Park; Karen Staehling; Mark Tsang; Mark W Appleby; Mary E Brunkow; Daciana Margineantu; David M Hockenbery; Tania Habib; H Denny Liggitt; George Carlson; Brian M Iritani
Journal:  Immunity       Date:  2012-05-17       Impact factor: 31.745

2.  Oncogene-independent BCR-like signaling adaptation confers drug resistance in Ph-like ALL.

Authors:  Christian Hurtz; Gerald B Wertheim; Joseph P Loftus; Daniel Blumenthal; Anne Lehman; Yong Li; Asen Bagashev; Bryan Manning; Katherine D Cummins; Janis K Burkhardt; Alexander E Perl; Martin Carroll; Sarah K Tasian
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

Review 3.  X-linked hypogammaglobulinemia and isolated growth hormone deficiency: an update.

Authors:  Donn M Stewart; Lan Tian; Luigi D Notarangelo; David L Nelson
Journal:  Immunol Res       Date:  2008       Impact factor: 4.505

Review 4.  X-linked hypogammaglobulinemia and isolated growth hormone deficiency: an update.

Authors:  Donn M Stewart; Lan Tian; Luigi D Notarangelo; David L Nelson
Journal:  Immunol Res       Date:  2007       Impact factor: 4.505

5.  Ligand-independent signaling functions for the B lymphocyte antigen receptor and their role in positive selection during B lymphopoiesis.

Authors:  G Bannish; E M Fuentes-Pananá; J C Cambier; W S Pear; J G Monroe
Journal:  J Exp Med       Date:  2001-12-03       Impact factor: 14.307

6.  The B cell antigen receptor controls integrin activity through Btk and PLCgamma2.

Authors:  Marcel Spaargaren; Esther A Beuling; Mette L Rurup; Helen P Meijer; Melanie D Klok; Sabine Middendorp; Rudolf W Hendriks; Steven T Pals
Journal:  J Exp Med       Date:  2003-11-10       Impact factor: 14.307

7.  Bruton's tyrosine kinase cooperates with the B cell linker protein SLP-65 as a tumor suppressor in Pre-B cells.

Authors:  Rogier Kersseboom; Sabine Middendorp; Gemma M Dingjan; Katarina Dahlenborg; Michael Reth; Hassan Jumaa; Rudolf W Hendriks
Journal:  J Exp Med       Date:  2003-06-30       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.